The selective estrogen receptor modulator trioxifene (LY133314) inhibits metastasis and extends survival in the PAIII rat prostatic carcinoma model.

Neubauer, Blake Lee

The selective estrogen receptor modulator trioxifene (LY133314) inhibits metastasis and extends survival in the PAIII rat prostatic carcinoma model. [electronic resource] - Cancer research Sep 2003 - 6056-62 p. digital

Publication Type: Journal Article

0008-5472


Adenocarcinoma--drug therapy
Animals
Body Weight--drug effects
Cell Division--drug effects
Disease Models, Animal
Estrogen Receptor alpha
Estrogen Receptor beta
Genitalia, Male--drug effects
Luciferases--antagonists & inhibitors
Lung Neoplasms--prevention & control
Lymphatic Metastasis
Male
Organ Size--drug effects
Prostatic Neoplasms--drug therapy
Pyrrolidines--metabolism
Rats
Receptors, Androgen--biosynthesis
Receptors, Estrogen--biosynthesis
Selective Estrogen Receptor Modulators--metabolism
Testis--anatomy & histology